In previous studies, we demonstrated that SHD can alleviate depression-like behavior and intestinal mucosal injury by modulating the gut microbiota (Yue et al., 2021), but few studies elaborated light on its therapeutic mechanism on tryptophan metabolism and AMPK/mTOR pathway. This evidence concerns the gene MTOR and depressive symptom measurement.